Breaking News Headlines Today

News about GLP-1

Stay current with all the latest and breaking news about GLP-1, compare headlines and perspectives between news sources on stories happening today. In total, 966 stories have been published about GLP-1 which Ground News has aggregated in the past 3 months.

Covered Most By

Anti-Aging, Acupuncture and Health News

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top GLP-1 News

Obesity · United States

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

86% Center coverage: 7 sources

NEW YORK--(BUSINESS WIRE)--Feb 3, 2026-See the Story

Diabetes

Novo Nordisk's Next-Gen Combination Drug Beats Semaglutide in Weight Loss and Blood Sugar Control - Novo Nordisk (NYSE:NVO)

80% Center coverage: 5 sources

Novo Nordisk A/S (NYSE:NVO) on Monday shared headline results from the REIMAGINE 2 phase 3 trial from the global REIMAGINE clinical trial program. CagriSema for weight management was submitted to the U.S. Food and Drug Administration (FDA) in December 2025 based on the REDEFINE 1 and REDEFINE 2 pivotal trials. Trial Data REIMAGINE 2 was a 68-week efficacy and safety trial investigating once-weekly subcutaneous CagriSema (a fixed dose combination…See the Story

Coronavirus · New York

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Coverage: 4 sources

NEW YORK--(BUSINESS WIRE)--Feb 3, 2026-See the Story

The Cruel Fate of the Rapidly Increasing Number of "Miracle Weight Loss Drugs" in Japan. Why Are so Many People in the Us, Which Is Ahead of the Us, Now Despairing over the "Metabolic Anthill"?

The number of people using the diabetes drug GLP-1 for weight loss purposes is increasing in Japan. Among the several similar drugs, "Manjaro" is approved in Japan as a treatment for type 2 diabetes, but there are cases where beauty clinics and other institutions prescribe it as an elective treatment...GLP-1 · Japan Read Article

More GLP-1 Drug Lawsuits; Military's Rising Obesity Rates; Male Birth Control Soon?

(MedPage Today) — More lawsuits are alleging that patients are not being sufficiently warned of certain severe injuries associated with GLP-1 receptor agonists. (USA Today) Meanwhile, the U.K.’s Medicines and Healthcare Products Regulatory Agency… Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119713 Author : Publish date : 2026-02-03 19:59:00 Copyright for syndicated content belongs to the linked Source. The post …GLP-1 · United Kingdom Read Article

Rethinking weight loss in the Ozempic era: Researchers urge a more holistic view

100% Center coverage: 1 sources

In the world of obesity research, the arrival of GLP-1 drugs like Ozempic feels seismic. At a recent conference, Martin Binks, a leader in obesity research, found himself marveling with a colleague: "Can you believe we finally reached this moment, that we lived long enough to see this?"Ozempic · Australia Read Article

Why PepsiCo Is Betting on Fiber as the ‘Next Protein’

100% Center coverage: 1 sources

Consumers are starting to add more fiber to their diets, especially amid wider GLP-1 adoption.GLP-1 See the Story

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

86% Center coverage: 7 sources

NEW YORK--(BUSINESS WIRE)--Feb 3, 2026-Obesity · United States See the Story

SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes

SGLT2 inhibitors were linked to better kidney outcomes than GLP-1 receptor agonists in Type 2 diabetes. Learn more about the clinical impact.GLP-1 Read Article

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Coverage: 4 sources

NEW YORK--(BUSINESS WIRE)--Feb 3, 2026-Coronavirus · New York See the Story

Girl, 7, hospitalised and left 'lifeless' after injecting herself with weight loss drugs

100% Left coverage: 3 sources

A seven-year-old girl was rushed to hospital after injecting herself with a GLP-1 weight loss medication, mistaking it for stomach medicineEurope · United Kingdom See the Story

How protein rose to the top of the food chain

100% Right coverage: 1 sources

Eating more protein is in vogue, thanks to popular diets, the power of social media influencers and the advent of GLP-1 weight-loss drugs.Influencers · Australia Read Article

GLP-1s Linked to Reduced Bleeding in Intracranial Aneurysms

Use of GLP-1s is linked to lower risk for subarachnoid hemorrhage and mortality in patients with intracranial aneurysms and type 2 diabetes compared to use of other agents, a new study shows. Medscape Medical News Source link : https://www.medscape.com/viewarticle/glp-1s-linked-reduced-bleeding-risk-intracranial-aneurysms-2026a10003ai?src=rss Author : Publish date : 2026-02-03 05:14:00 Copyright for syndicated content belongs to the linked Sourc…GLP-1 Read Article

News about GLP-1

News about GLP-1

Covered Most By

Local News Publishers

Top GLP-1 News

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

Novo Nordisk's Next-Gen Combination Drug Beats Semaglutide in Weight Loss and Blood Sugar Control - Novo Nordisk (NYSE:NVO)

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

The Cruel Fate of the Rapidly Increasing Number of "Miracle Weight Loss Drugs" in Japan. Why Are so Many People in the Us, Which Is Ahead of the Us, Now Despairing over the "Metabolic Anthill"?

More GLP-1 Drug Lawsuits; Military's Rising Obesity Rates; Male Birth Control Soon?

Rethinking weight loss in the Ozempic era: Researchers urge a more holistic view

Why PepsiCo Is Betting on Fiber as the ‘Next Protein’

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Girl, 7, hospitalised and left 'lifeless' after injecting herself with weight loss drugs

How protein rose to the top of the food chain

GLP-1s Linked to Reduced Bleeding in Intracranial Aneurysms

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to GLP-1

The Cruel Fate of the Rapidly Increasing Number of "Miracle Weight Loss Drugs" in Japan. Why Are so Many People in the Us, Which Is Ahead of the Us, Now Despairing over the "Metabolic Anthill"?

More GLP-1 Drug Lawsuits; Military's Rising Obesity Rates; Male Birth Control Soon?

Rethinking weight loss in the Ozempic era: Researchers urge a more holistic view

Why PepsiCo Is Betting on Fiber as the ‘Next Protein’

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Girl, 7, hospitalised and left 'lifeless' after injecting herself with weight loss drugs

How protein rose to the top of the food chain

GLP-1s Linked to Reduced Bleeding in Intracranial Aneurysms

News about GLP-1

News about GLP-1

Covered Most By

Local News Publishers Too Big Arrow Icon

Top GLP-1 News

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

Novo Nordisk's Next-Gen Combination Drug Beats Semaglutide in Weight Loss and Blood Sugar Control - Novo Nordisk (NYSE:NVO)

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

The Cruel Fate of the Rapidly Increasing Number of "Miracle Weight Loss Drugs" in Japan. Why Are so Many People in the Us, Which Is Ahead of the Us, Now Despairing over the "Metabolic Anthill"?

More GLP-1 Drug Lawsuits; Military's Rising Obesity Rates; Male Birth Control Soon?

Rethinking weight loss in the Ozempic era: Researchers urge a more holistic view

Why PepsiCo Is Betting on Fiber as the ‘Next Protein’

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Girl, 7, hospitalised and left 'lifeless' after injecting herself with weight loss drugs

How protein rose to the top of the food chain

GLP-1s Linked to Reduced Bleeding in Intracranial Aneurysms

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to GLP-1

The Cruel Fate of the Rapidly Increasing Number of "Miracle Weight Loss Drugs" in Japan. Why Are so Many People in the Us, Which Is Ahead of the Us, Now Despairing over the "Metabolic Anthill"?

More GLP-1 Drug Lawsuits; Military's Rising Obesity Rates; Male Birth Control Soon?

Rethinking weight loss in the Ozempic era: Researchers urge a more holistic view

Why PepsiCo Is Betting on Fiber as the ‘Next Protein’

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Girl, 7, hospitalised and left 'lifeless' after injecting herself with weight loss drugs

How protein rose to the top of the food chain

GLP-1s Linked to Reduced Bleeding in Intracranial Aneurysms

Local News Publishers